title: "ROADMAP" controversies.
authors.affiliation: Department of Medicine, Hypertension Program, University of Pennsylvania, School of Medicine, Philadelphia, PA 19104, USA. cohendl@mail.med.upenn.edu
authors.forename: Debbie L
authors.initials: DL
authors.lastname: Cohen
authors.forename: Raymond R
authors.initials: RR
authors.lastname: Townsend
mesh_terms: D000419:Albuminuria / Q000209:etiology / Q000517:prevention & control*; D057911:Angiotensin Receptor Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000401:mortality*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects* / Q000627:therapeutic use*; D015995:Prevalence; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013777:Tetrazoles / Q000009:adverse effects* / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D057911:Angiotensin Receptor Antagonists; D007093:Imidazoles; D013777:Tetrazoles; C437965:olmesartan